ICD-10-CM Code D09.3

Carcinoma in situ of thyroid and other endocrine glands

Version 2020 Billable Code Neoplasm CaInSitu

Valid for Submission

D09.3 is a billable code used to specify a medical diagnosis of carcinoma in situ of thyroid and other endocrine glands. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code D09.3 might also be used to specify conditions or terms like carcinoma in situ of adrenal cortex, carcinoma in situ of adrenal gland, carcinoma in situ of adrenal medulla, carcinoma in situ of craniopharyngeal duct, carcinoma in situ of endocrine gland, carcinoma in situ of multiple endocrine glands, etc

ICD-10:D09.3
Short Description:Carcinoma in situ of thyroid and other endocrine glands
Long Description:Carcinoma in situ of thyroid and other endocrine glands

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D09.3:

Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • carcinoma in situ of endocrine pancreas D01.7
  • carcinoma in situ of ovary D07.39
  • carcinoma in situ of testis D07.69

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Carcinoma in situ of adrenal cortex
  • Carcinoma in situ of adrenal gland
  • Carcinoma in situ of adrenal medulla
  • Carcinoma in situ of craniopharyngeal duct
  • Carcinoma in situ of endocrine gland
  • Carcinoma in situ of multiple endocrine glands
  • Carcinoma in situ of parathyroid gland
  • Carcinoma in situ of pineal gland
  • Carcinoma in situ of pituitary gland
  • Carcinoma in situ of thyroglossal duct
  • Carcinoma in situ of thyroid gland
  • Malignant tumor of thymus
  • Neoplasm of adrenal cortex
  • Neoplasm of craniopharyngeal duct
  • Neoplasm of parathyroid gland
  • Neoplasm of thyroglossal duct
  • Primary malignant neoplasm of thymus
  • Primary squamous cell carcinoma of thymus

Diagnostic Related Groups

The ICD-10 code D09.3 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 826 - MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MCC
  • 827 - MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH CC
  • 828 - MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT CC/MCC

Convert D09.3 to ICD-9

  • 234.8 - Ca in situ NEC (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of other and unspecified sites (D09)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code D09.3 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

The Tabular must be reviewed for the complete diagnosis code.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»adrenal
C74.9C79.7D09.3D35.0D44.1D49.7
»adrenal
  »capsule
C74.9C79.7D09.3D35.0D44.1D49.7
»adrenal
  »cortex
C74.0C79.7D09.3D35.0D44.1D49.7
»adrenal
  »gland
C74.9C79.7D09.3D35.0D44.1D49.7
»adrenal
  »medulla
C74.1C79.7D09.3D35.0D44.1D49.7
»cortex
C74.0C79.7D09.3D35.0D44.1D49.7
»cortex
  »adrenal
C74.0C79.7D09.3D35.0D44.1D49.7
»craniobuccal pouch
C75.2C79.89D09.3D35.2D44.3D49.7
»craniopharyngeal (duct) (pouch)
C75.2C79.89D09.3D35.3D44.4D49.7
»endocrine gland NEC
C75.9C79.89D09.3D35.9D44.9D49.7
»endocrine gland NEC
  »pluriglandular
C75.8C79.89D09.3D35.7D44.9D49.7
»fossa (of)
  »pituitary
C75.1C79.89D09.3D35.2D44.3D49.7
»gland, glandular (lymphatic) (system) [See Also: Neoplasm, lymph gland]
C75.9C79.89D09.3D35.9D44.9D49.7
»gland, glandular (lymphatic) (system) [See Also: Neoplasm, lymph gland]
  »endocrine NEC
C75.9C79.89D09.3D35.9D44.9D49.7
»hypophysis
C75.1C79.89D09.3D35.2D44.3D49.7
»intrasellar
C75.1C79.89D09.3D35.2D44.3D49.7
»medulla
C74.1C79.7D09.3D35.0D44.1D49.7
»medulla
  »adrenal
C74.1C79.7D09.3D35.0D44.1D49.7
»parathyroid (gland)
C75.0C79.89D09.3D35.1D44.2D49.7
»pineal (body) (gland)
C75.3C79.89D09.3D35.4D44.5D49.7
»pituitary (body) (fossa) (gland) (lobe)
C75.1C79.89D09.3D35.2D44.3D49.7
»pluriendocrine
C75.8C79.89D09.3D35.7D44.9D49.7
»Rathke's pouch
C75.1C79.89D09.3D35.2D44.3D49.7
»sella turcica
C75.1C79.89D09.3D35.2D44.3D49.7
»suprarenal
C74.9C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »capsule
C74.9C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »cortex
C74.0C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »gland
C74.9C79.7D09.3D35.0D44.1D49.7
»suprarenal
  »medulla
C74.1C79.7D09.3D35.0D44.1D49.7
»thymus (gland)
C37C79.89D09.3D15.0D38.4D49.89
»thyroglossal duct
C73C79.89D09.3D34D44.0D49.7
»thyroid (gland)
C73C79.89D09.3D34D44.0D49.7

Information for Patients


Thyroid Cancer

Your thyroid is a butterfly-shaped gland in your neck, just above your collarbone. It makes hormones that help the body work normally. There are several types of cancer of the thyroid gland. You are at greater risk if you

  • Are between ages 25 and 65
  • Are a woman
  • Are Asian
  • Have a family member who has had thyroid disease
  • Have had radiation treatments to your head or neck

You should see a doctor if you have a lump or swelling in your neck. Doctors use a physical exam, thyroid tests, other blood and imaging tests, and a biopsy to diagnose thyroid cancer. Treatment depends on the type of cancer you have and how far the cancer has spread. Many patients receive a combination of treatments. They may include surgery, radioactive iodine, hormone treatment, radiation therapy, chemotherapy, or targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


[Learn More]